v3.26.1
Organization and Nature of Operations (Details Narrative) - USD ($)
12 Months Ended
Jan. 06, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net income (loss) available to common stockholders   $ (36,068,870)    
Net cash used in operations   (21,293,152) $ (21,310,603)  
Accumulated deficit   (96,984,297) (60,915,427)  
Stockholders equity   15,402,819 (15,261,613) $ (28,403,464)
Working capital   11,210,470    
Cash and cash equivalent   1,731,400 $ 11,790,389  
Convertible secured note   $ 1,000,000    
Board of Directors Chairman [Member]        
Convertible secured note $ 20,000,000